Home
News
Create
Screeners
Insights
Biogen Pharmachem
0.
59
-0.01
(-1.67%)
Market Cap
₹53.30 Cr
PE Ratio
20.00
Industry
Financial Services
Buy
Sell
Company Performance:
1D
-1.67%
1M
-15.71%
6M
-35.16%
1Y
-44.86%
5Y
+180.95%
View Company Insights
Latest news about Biogen Pharmachem
Biogen Pharmachem: Company Plans To Review Bonus Share Issue On March 23
Feb 24, 2026
Biogen Pharmachem Industries Limited has announced a board meeting scheduled for March 23, 2026, to consider the declaration of bonus shares. The meeting will be held at the company's registered office and follows SEBI (LODR) Regulations, 2015 compliance requirements. The proposed bonus share issuance remains subject to shareholder approval and represents a potential value addition for existing shareholders.
Biogen Pharmachem Industries Limited Schedules Board Meeting for February 3, 2026 to Consider Q3FY26 Financial Results
Jan 19, 2026
Biogen Pharmachem Industries Submits Q3FY26 SEBI Compliance Certificate
Jan 05, 2026
Biogen Pharmachem Industries Reports Impressive Turnaround with Rs 134.48 Lakh Net Profit in Q1
Jul 23, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO